Esperion Therapeutics Inc. (ESPR) Soars 6.36% on March 12

Equities Staff  |

Esperion Therapeutics Inc. (ESPR) had a good day on the market for Monday March 12 as shares jumped 6.36% to close at $80.05. About 1.63 million shares traded hands on 13,535 trades for the day, compared with an average daily volume of 593,841 shares out of a total float of 26.5 million. After opening the trading day at $71.00, shares of Esperion Therapeutics Inc. stayed within a range of $81.29 to $70.50.

With today's gains, Esperion Therapeutics Inc. now has a market cap of $2.12 billion. Shares of Esperion Therapeutics Inc. have been trading within a range of $82.68 and $20.39 over the last year, and it had a 50-day SMA of $72.68 and a 200-day SMA of $54.18.

Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.

Esperion Therapeutics Inc. is based out of Ann Arbor, MI and has some 57 employees. Its CEO is Timothy M. Mayleben.

For a complete fundamental analysis of Esperion Therapeutics Inc., check out’s Stock Valuation Analysis report for ESPR.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

Esperion Therapeutics Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Esperion Therapeutics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ESPR’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Crypto World in Review: Taking in the Good with the Bad

A lot happened in the cryptocurrency industry this week.

Emerging Growth

DirectView Holdings Inc

DirectView Holdings Inc designs and installs surveillance systems, digital video recording and services. The company through its subsidiaries operates within two divisions security and surveillance and video conferencing services.